This chemical is primarily utilized in the development of pharmaceuticals, particularly in the treatment of metabolic disorders. It acts as a key intermediate in the synthesis of SGLT2 inhibitors, which are a class of drugs used to manage type 2 diabetes by promoting glucose excretion through urine. Its structure is crucial for enhancing the drug's selectivity and efficacy, ensuring minimal side effects while maintaining therapeutic benefits. Additionally, it is explored in research for potential applications in cardiovascular and renal diseases due to its ability to modulate glucose and sodium reabsorption. Its role in drug development underscores its importance in advancing treatments for chronic conditions.